Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENVB | AMGN | VRTX | REGN | BMY |
| Company | Enveric Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.9000 | 301.75 | 406.42 | 967.88 | 43.98 |
| High | 0.9200 | 302.76 | 409.48 | 967.88 | 44.20 |
| Low | 0.9000 | 299.92 | 394.03 | 958.91 | 43.90 |
| Last | 0.9400 | 300.19 | 407.11 | 962.66 | 44.00 |
| Change | +0.0200 | +0.71 | +4.61 | +4.02 | +0.10 |
| % Change | +2.17% | +0.24% | +1.15% | +0.42% | +0.23% |
| Volume | 33,753 | 338,309 | 408,255 | 41,048 | 1,112,867 |
| 20-Day Average Volume | 120,192 | 2,711,389 | 1,034,762 | 505,650 | 13,864,834 |
| Previous Close | 0.9200 | 299.48 | 402.50 | 958.64 | 43.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9207 | 275.40 | 398.06 | 911.83 | 46.73 |
| 20-Day Raw Stochastic | 25.37% | 67.73% | 47.17% | 94.65% | 9.90% |
| 20-Day Relative Strength | 45.66% | 64.01% | 45.49% | 60.50% | 30.45% |
| Weighted Alpha | -79.76 | +29.52 | +13.46 | +29.46 | -35.94 |
| Today's Opinion | 100% Sell | 40% Buy | 8% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 80% Sell | 24% Sell | 24% Buy | 56% Buy | 32% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.26% since 04/30/24 | +10.47% since 04/30/24 | +1.53% since 04/30/24 | +8.11% since 04/30/24 | +0.41% since 04/30/24 |
| Low | 0.9000 on 05/07/24 | 273.38 on 05/01/24 | 392.47 on 05/01/24 | 888.52 on 05/01/24 | 43.33 on 05/02/24 |
| High | 1.0200 on 05/03/24 | 322.60 on 05/03/24 | 407.59 on 05/06/24 | 967.88 on 05/07/24 | 44.62 on 05/06/24 |
| 1-Month | |||||
| %Chg | -3.23% since 04/05/24 | +12.10% since 04/05/24 | -1.93% since 04/05/24 | +2.15% since 04/05/24 | -14.03% since 04/05/24 |
| Low | 0.8558 on 04/23/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.0300 on 04/12/24 | 322.60 on 05/03/24 | 407.59 on 05/06/24 | 967.88 on 05/07/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | +10.12% since 02/07/24 | +2.28% since 02/07/24 | -4.83% since 02/07/24 | +2.60% since 02/07/24 | -9.29% since 02/07/24 |
| Low | 0.7700 on 02/12/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 2.9200 on 02/29/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -50.00% since 11/07/23 | +11.62% since 11/07/23 | +5.44% since 11/07/23 | +15.90% since 11/07/23 | -15.62% since 11/07/23 |
| Low | 0.6490 on 02/01/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 2.9200 on 02/29/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,710 | 160,633,888 | 104,029,752 | 105,222,248 | 88,989,688 |
| Shares Outstanding, K | 7,294 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -17,290,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -3,440,000 | -113,000,000 | 968,800,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.82 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.46 on 03/25/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 29.84 | 25.79 | 41.90 |